Changeflow GovPing Pharma & Drug Safety USPTO Patent Application for Skin Care Formulat...
Routine Notice Added Final

USPTO Patent Application for Skin Care Formulations

Favicon for changeflow.com ChangeBridge: Patent Apps - Pharma (A61K)
Published December 4th, 2025
Detected March 26th, 2026
Email

Summary

The USPTO has published a patent application (US20260083651A1) for skin care formulations. The application details a method of treating skin and a topical composition including various extracts and active ingredients. The filing date for this application was December 4, 2025.

What changed

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083651A1, related to skin care formulations. The application, filed on December 4, 2025, describes a method for treating skin using a topical composition that includes Lactobacillus ferment, Punica granatum extract, Camellia sinensis leaf extract, cucumber extract, dipotassium glycyrrhizate, sodium hyaluronate, glycerin, and butylene glycol.

This publication represents a new patent application and does not impose immediate regulatory obligations on companies. However, it is relevant for pharmaceutical and cosmetic manufacturers to be aware of potential intellectual property developments in the skincare sector. Companies developing similar formulations should review the patent claims to ensure they do not infringe on this potential patent once granted.

What to do next

  1. Review patent application US20260083651A1 for potential IP conflicts.
  2. Monitor patent prosecution status for potential grant.

Source document (simplified)

← USPTO Patent Applications

SKIN CARE FORMULATIONS

Application US20260083651A1 Kind: A1 Mar 26, 2026

Inventors

Dawn BURKE-COLVIN, Michelle HINES, David GAN

Abstract

A method of treating skin and a topical skin care composition are disclosed. The method includes topically applying to a person's skin a composition that can include Lactobacillus ferment, Punica granatum extract, Camellia sinensis leaf extract, cucumber extract, dipotassium glycyrrhizate, sodium hyaluronate, glycerin, and butylene glycol, wherein the person's skin is treated.

CPC Classifications

A61K 8/345 A61K 8/41 A61K 8/585 A61K 8/64 A61K 8/9789 A61Q 1/00 A61Q 19/00 A61Q 19/02 A61Q 19/08 A61Q 19/10 A61K 2800/85

Filing Date

2025-12-04

Application No.

19409573

View original document →

Named provisions

SKIN CARE FORMULATIONS Inventors Abstract CPC Classifications Filing Date Application No.

Classification

Agency
USPTO
Published
December 4th, 2025
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083651A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product Development Intellectual Property Management
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Cosmetics Intellectual Property

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Pharma (A61K) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.